Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Access to Medicines index released, clinical trial of injectable ARV, and Zika vaccine clears early trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Budget compromise re-opens the federal government

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about the new budget compromise that re-opened the federal government, as well as the effect of the government shutdown on health research programs.

GHTC
Read More
Vaccinate against the brain drain

In this guest post, Elisabeth Wilhelm, senior media specialist at the International AIDS Vaccine Initiative (IAVI), writes about the need to invest in the next generation of researchers and scientists in sub-Saharan Africa.

Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New tool to understand global health regulatory requirements

In this guest post, Tricia Aung—the GHTC’s regulatory associate—writes about a new database that provides easy access to information on global health regulatory information.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
How did health research fare at the UN General Assembly?

After a busy week of negotiating police barricades and security checks in New York during the United Nations General Assembly (UNGA), we’re back in Washington, DC, with more thinking about the post-2015 development agenda and some reflections about what was heard throughout the week.

GHTC
Read More
What’s ahead on the Hill: An update on the government shutdown and global health R&D programs

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about how the government shutdown and budget negotiations in Congress will impact global health research and development (R&D) programs across the federal government.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New technologies in family planning

In this guest post, Dr. Judy Manning from the US Agency for International Development (USAID) and Dr. Zeda Rosenberg from the International Partnership for Microbicides (IPM) discuss the need for new and improved contraceptive options for women worldwide.

Read More
The power to save millions of lives

In this guest post, Rachel Wilson—senior director of Policy and Advocacy at PATH—writes about a new report focused on health innovations for women and children worldwide.

PATH
Read More
A big week for global health, innovation, and the post-2015 development agenda

This week, many GHTC members will be in New York for the sixty-eighth session of the United Nations’ General Assembly (UNGA), where, among other topics, progress toward meeting the Millennium Development Goals (MDGs) will be addressed.

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New GHTC resources highlight FDA’s critical role in global health

The GHTC has long stressed that the US Food and Drug Administration (FDA) plays a critical part in efforts to improve global public health.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New paper examines research funding for diseases and conditions of poverty

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key funding challenges and opportunities for global health research and development (R&D).

PATH
Read More
What’s ahead on the Hill: The top five priorities for Congress before the end of 2013

Now that Labor Day has passed and Washington, DC, is starting to cool down, members of Congress are filtering back into town from their August recess travels.

GHTC
Read More
PATH/Lesley Reed
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
More good news for global health R&D as the UK ramps up its investment in product development

Close on the heels of the announcement that Australia is newly investing in global health product development, the United Kingdom last week also revealed that it’s bumping up its longstanding support in this area.

GHTC
Read More
What comes to mind when you think of drug development?

Ever feel like you can’t see the forest for the trees?

GHTC
Read More
Australia’s evolving role in global health R&D

In a notable move for global health research efforts, Australia this week announced funding for four groups developing new drugs, vaccines, and diagnostics for malaria and tuberculosis (TB).

GHTC
Read More